Challenges in treating malignancies in HIV in Nigeria.

Abstract:

PURPOSE OF REVIEW:Sub-Saharan Africa has the largest population of people living with AIDS in the world, with Nigeria having the third largest after South Africa and India. With the advent of treatment programs, more people in Nigeria are now living with the virus but are at increased risk of cancer similar to the experience in other parts of the world. This review uses publications on HIV-associated cancers emanating from Nigeria in 2008 to map the current landscape of prevention, diagnosis and treatment of these conditions. The opportunities and challenges identified in this review will provide a template for designing appropriate clinical and public health intervention to stem another epidemic, this time of AIDS-associated malignancies. RECENT FINDINGS:There is a paucity of literature on AIDS-associated cancers from Nigeria, and most reports are based on hospital or pathology case series. Poor case identification and diagnosis and rudimentary cancer registration militate against adequate quantification of the prevalence of AIDS-associated cancers in Nigeria. Several initiatives, working with the HIV treatment programs, governmental and nongovernmental local and international agencies, are rising to the challenge and creating new opportunities for cancer prevention, treatment and research that takes advantage of improved treatment infrastructure provided for people living with HIV/AIDS. SUMMARY:Nigeria is about to witness substantial increase in the background incidence of cancers due to high prevalence of HIV and expanded treatment programs. Creative methods are needed to deploy effective prevention, case identification, registration and treatment programs that are consistent with the socioeconomic development of the country.

journal_name

Curr Opin Oncol

authors

Akinwande O,Ogundiran T,Akarolo-Anthony S,Mamadu I,Dakum P,Blattner W,Adebamowo C

doi

10.1097/CCO.0b013e32832e6385

subject

Has Abstract

pub_date

2009-09-01 00:00:00

pages

455-61

issue

5

eissn

1040-8746

issn

1531-703X

journal_volume

21

pub_type

杂志文章,评审
  • Mucosal protectants and their application for head and neck chemoirradiation.

    abstract::Mucosal injury due to ionizing radiation or cytotoxic agents begins with damage to stem cells in the basal epithelium, progresses as these cells are depleted, and is complicated by inflammation and superimposed infection. Suppression of oral and pharyngeal infection, cytokine stimulation of neutrophils, and protection...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199709030-00009

    authors: Marks JE

    更新日期:1997-05-01 00:00:00

  • Adenocarcinoma of the small bowel: changes in the landscape?

    abstract:PURPOSE OF REVIEW:Small bowel adenocarcinoma (SBA) is a rare cancer with a poor prognosis and little information to guide its management. In recent years, improved diagnostic imaging and an increase in reported experience with use of chemotherapy may alter the way we manage SBA. This review will summarize recent advanc...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833a86fe

    authors: Speranza G,Doroshow JH,Kummar S

    更新日期:2010-07-01 00:00:00

  • Therapy for small cell and non-small cell lung cancer.

    abstract::This review addresses means for improving treatment results in small cell and non-small cell lung cancer. In small cell lung cancer lactate dehydrogenase and neuron-specific enolase seem to be important prognostic factors that may reflect not only tumor load but also growth rate. Chemotherapy seems to induce or select...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199204000-00013

    authors: Splinter TA

    更新日期:1992-04-01 00:00:00

  • Atypical lipomatous tumor: molecular characterization.

    abstract:PURPOSE OF REVIEW:Atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLs) are one of the more frequent mesenchymal neoplasms and are characterized by specific chromosome aberrations: supernumerary chromosome or giant marker chromosome or both. Extra copies of known oncogenes such as MDM2, CDK4, SAS, HMGA...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000127878.85125.53

    authors: Arrigoni G,Doglioni C

    更新日期:2004-07-01 00:00:00

  • State-of-the-art of bone marrow imaging in multiple myeloma.

    abstract:PURPOSE OF REVIEW:Multiple myeloma is a common hematological malignancy arising in the bone marrow. Bone lesions were initially depicted with conventional radiography, although recently F-FDG PET/CT and MRI are recognized as having a clear role in the initial workup and in the evaluation of therapy response. RECENT FI...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000230

    authors: Martí-Bonmatí L,Ramirez-Fuentes C,Alberich-Bayarri Á,Ruiz-Llorca C

    更新日期:2015-11-01 00:00:00

  • Hematopoietic stem cell transplantation for AIDS-related malignancies.

    abstract:PURPOSE OF REVIEW:AIDS-related malignancies are an ongoing cause of mortality in individuals with HIV infection. In the HIV-negative setting, high-dose chemotherapy or stem cell transplantation is an option for patients with hematologic malignancies. Prior to the advent of effective HIV therapy, stem cell transplantati...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833d2cf0

    authors: Krishnan A,Forman SJ

    更新日期:2010-09-01 00:00:00

  • Update on the pathogenesis and treatment of Kaposi sarcoma.

    abstract::Kaposi sarcoma (KS), an unusual tumor of vascular origin, was one of the first recognized manifestations of AIDS. In the past few years, it has become clear that human herpesvirus-8 (HHV-8) is critical to the development of KS in the setting of immunosuppression, such as that seen with HIV infection. Other genetic and...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200003000-00013

    authors: Mitsuyasu RT

    更新日期:2000-03-01 00:00:00

  • Paraendocrine syndromes.

    abstract::Paraendocrine syndromes are the remote effects of cancer that result from ectopic hormonal production. Recent investigations have concentrated in five areas that include the evaluation of diagnostic studies, the recognition of rare cases, the contribution of secondary hormones, the clinical distinctions of ectopic syn...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199307000-00004

    authors: Pierce ST

    更新日期:1993-07-01 00:00:00

  • Three molecular determinants of malignant conversion and their potential as therapeutic targets.

    abstract::The past decade has been marked by an explosion of knowledge regarding the dysregulation of cancer at the molecular level. It has become apparent that oncogenes, tumor suppressor genes, and other ancillary molecules interact in complex pathways that govern cellular homeostasis. We review three molecular events that ha...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199901000-00013

    authors: Dome JS,Look AT

    更新日期:1999-01-01 00:00:00

  • Critical care management of cancer patients: cause for optimism and need for objectivity.

    abstract:PURPOSE OF REVIEW:In the 1990s, cancer patients were described as poor candidates for ICU admission on the basis of high mortality rates and management costs. Over the last decade, however, advances in the management of malignancies and organ failures have led to substantial increases in survival. This review discusses...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32832b68b6

    authors: Darmon M,Azoulay E

    更新日期:2009-07-01 00:00:00

  • Therapy-related myeloid neoplasms.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to update knowledge on therapy-related myeloid neoplasms (t-MN), taking into account the new 2008 WHO classification, new genome-wide approaches for the definition of susceptibility towards t-MN and the introduction of new more aggressive treatments in cancer patients. R...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32834bcc2a

    authors: Leone G,Fianchi L,Voso MT

    更新日期:2011-11-01 00:00:00

  • Cutaneous manifestations of cancer.

    abstract::The appearance of skin lesions in patients with occult or obvious malignancy may be of extreme value in the detection and management of cancer because the skin is readily accessible to examination and biopsy. Examination of the skin of our patients can provide important insights into underlying malignant processes or ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199903000-00011

    authors: Sabir S,James WD,Schuchter LM

    更新日期:1999-03-01 00:00:00

  • Vandetanib and the management of advanced medullary thyroid cancer.

    abstract:PURPOSE OF REVIEW:Vandetanib is a small molecule tyrosine kinase inhibitor that has been recently approved as an 'orphan drug' for the treatment of patients with unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC). RECENT FINDINGS:MTC is a neuroendocrine malignancy frequently associated with m...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835a42b9

    authors: Campbell MJ,Seib CD,Gosnell J

    更新日期:2013-01-01 00:00:00

  • Tyrosine kinase inhibitors-ZD1839 (Iressa).

    abstract::Several epithelial tumors display epidermal growth factor receptor (EGFR) overexpression (with or without EGFR gene amplification) that is often associated with increased production of EGFR ligands. This permits the activation of endogenous tumor EGFR via autocrine mechanisms, resulting in cellular proliferation and t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200111000-00012

    authors: Arteaga CL,Johnson DH

    更新日期:2001-11-01 00:00:00

  • Bone marrow transplantation for chronic myelogenous leukemia.

    abstract::It is generally accepted that patients with chronic myelogenous leukemia in chronic phase under the age of 50 years who have HLA-identical siblings, should be offered bone marrow transplantation within the first year of diagnosis. The projected disease-free survival for these patients is 70% to 80% at 4 years, and mos...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199204000-00004

    authors: Goldman JM

    更新日期:1992-04-01 00:00:00

  • Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer.

    abstract:PURPOSE OF REVIEW:Differentiated thyroid cancer (DTC), with a rapidly increasing incidence is the most common endocrine malignancy, but with generally favorable survival. Total thyroidectomy with 'therapeutic' cervical lymph node dissection for involved lymph nodes is the standard of care. A more controversial topic is...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328333ac97

    authors: Carling T,Long WD 3rd,Udelsman R

    更新日期:2010-01-01 00:00:00

  • The type II transforming growth factor-beta receptor as a tumor-suppressor gene.

    abstract::Recent work has shown that: 1) loss of transforming growth factor-beta response is associated with malignant progression, 2) maintenance of autocrine negative transforming growth factor-beta activity is a key impediment to malignant progression, and 3) the major mechanism for loss of RII expression in replication erro...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199601000-00009

    authors: Brattain MG,Markowitz SD,Willson JK

    更新日期:1996-01-01 00:00:00

  • Role of the unfolded protein response in tumor cell characteristics and cancer outcome.

    abstract:PURPOSE OF REVIEW:In the present review, we discuss the possible role of the unfolded protein response (UPR) in the acquisition of tumor cell characteristics and in the prognosis of cancer outcome, which could assist and contribute to the development of more promising therapeutic strategies. RECENT FINDINGS:Accumulati...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000339

    authors: Galmiche A,Sauzay C,Chevet E,Pluquet O

    更新日期:2017-01-01 00:00:00

  • Immune-mediated respiratory adverse events of checkpoint inhibitors.

    abstract:PURPOSE OF REVIEW:Immune checkpoint inhibitors have demonstrated remarkable efficacy with durable responses in the treatment of various malignancies. This new class of therapeutic agents is associated with a toxicity profile that differs from conventional cytotoxic therapy. The present review is focused on one of these...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000291

    authors: Tabchi S,Messier C,Blais N

    更新日期:2016-07-01 00:00:00

  • Osteosarcoma and other bone cancers.

    abstract::In this review, recent advances in the clinical therapy of osteosarcoma, including results from the European Osteosarcoma Intergroup trial demonstrating the efficacy of a short intensive two drug protocol are discussed as well the evolving role of ifosfamide. Biologically, the area of interest on chromosome 3q, which ...

    journal_title:Current opinion in oncology

    pub_type: 临床试验,杂志文章,评审

    doi:10.1097/00001622-199807000-00009

    authors: Himelstein BP

    更新日期:1998-07-01 00:00:00

  • Overcoming key challenges in cancer immunotherapy with engineered T cells.

    abstract:PURPOSE OF REVIEW:A number of clinical trials are currently testing chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered T cells for the treatment of haematologic malignancies and selected solid tumours, and CD19-CAR-T cells have produced impressive clinical responses in B-cell malignancies. Here, we su...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000664

    authors: Arcangeli S,Mestermann K,Weber J,Bonini C,Casucci M,Hudecek M

    更新日期:2020-09-01 00:00:00

  • Interferons in melanoma.

    abstract::The interferons are complex proteins that have been widely tested as therapy for neoplastic diseases. Interferon (IFN)-alpha has been the most extensively studied in melanoma. It produces responses in about 16% of metastatic melanomas, about one third of which are complete. It has been combined with chemotherapy and b...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199603000-00015

    authors: Agarwala SS,Kirkwood JM

    更新日期:1996-03-01 00:00:00

  • Approaches to relapse after allogeneic stem cell transplantation.

    abstract:PURPOSE OF REVIEW:Relapse has become the leading cause of death following allogeneic hematopoietic stem cell transplantation (HSCT). Despite improved understanding of the biology that underlies the graft-versus-leukemia/tumor effect the relapse rate did not decrease over the past 20 years. In general, prognosis is poor...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328342c6c8

    authors: Kröger N

    更新日期:2011-03-01 00:00:00

  • Testicular germ cell tumors.

    abstract:PURPOSE OF REVIEW:Preclinical and clinical developments in germ cell tumors over the past year are summarized. RECENT FINDINGS:Attenuations in the rising incidence of testicular germ cell tumors are beginning to be observed in certain European populations. Additional data on predisposing factors related to race, estro...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3280ad43df

    authors: Bridges B,Hussain A

    更新日期:2007-05-01 00:00:00

  • Neurological paraneoplastic syndromes: an update.

    abstract:PURPOSE OF REVIEW:To describe recent advances in the diagnosis and treatment of paraneoplastic neurological syndromes (PNS). RECENT FINDINGS:PNS are rare complications of cancer caused by an immune cross-reaction between antigens expressed by tumor cells and neurons. The target of the immune attack can be an intracell...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000479

    authors: Berzero G,Psimaras D

    更新日期:2018-11-01 00:00:00

  • Epidemiology and etiology of leukemia.

    abstract::New clinical and epidemiologic studies provide information about the possible causes of human leukemia. Evidence for a viral etiology continues to appear, and the relationship between myelodysplastic syndrome and the leukemias is now linked through molecular genetic studies. Molecular mechanisms of leukemogenesis are ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Vogel VG,Fisher RE

    更新日期:1993-01-01 00:00:00

  • Epidemiology, prevention, and early detection of breast cancer.

    abstract::Breast cancer is a leading women's health issue. Continued advances in understanding the temporal sequencing of relevant exposures promises to shed light on the continuum of breast carcinogenesis. Oral contraceptive use and the transient increase in risk following childbirth are exposures that affect the near-term ris...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199711000-00003

    authors: Alberg AJ,Helzlsouer KJ

    更新日期:1997-11-01 00:00:00

  • Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes.

    abstract:PURPOSE OF REVIEW:Tumor stroma is composed of many cellular subtypes, of which the most abundant are fibroblasts, macrophages and endothelial cells. During the process of tissue injury, these three cellular subtypes must coordinate their activity to efficiently contribute to tissue regeneration. In tumor, this mechanis...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000420

    authors: Ronca R,Van Ginderachter JA,Turtoi A

    更新日期:2018-01-01 00:00:00

  • Treatment advances in adult Burkitt lymphoma and leukemia.

    abstract:PURPOSE OF REVIEW:Despite significant improvements in the treatment of Burkitt lymphoma, outcomes of adults are generally inferior to those of children. This review summarizes the most recent developments in the management of Burkitt lymphoma and leukemia in adults. RECENT FINDINGS:Current regimens have largely been d...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200409000-00003

    authors: Kasamon YL,Swinnen LJ

    更新日期:2004-09-01 00:00:00

  • Modern treatment approaches for Hodgkin's disease.

    abstract::Recent studies are refining the treatment approaches of radiation therapy and combination chemotherapy in Hodgkin's disease. In early-stage disease, attempts are being made to lessen the toxicity of treatment while maintaining excellent results. Optimal results are achieved in advanced disease with combined radiation ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199309000-00003

    authors: Straus DJ

    更新日期:1993-09-01 00:00:00